2015-Special Issue 1: Oncology
24-34
Prostatic neoplasms, Castration-resistant, median overall survival (OS) remained in the 9-18
Advances in the management of esophageal cancer
What to expect from HER-2 directed therapies in advanced gastric cancer?
Zuleyha AKGUN, Esra KAYTAN SAGLAM
Treatment of prostate cancer by hypofractionated radiotherapy
CDK inhibitors in hormone receptor positive advanced breast cancer